Epigenetic carcinogens: Evaluation and risk assessment

https://doi.org/10.1016/S0940-2993(96)80041-8Get rights and content

Summary

Regulatory policies in the U.S. have been developed based upon a single model of cancer causation, which assumes chemical-induced genetic alterations. Such a model predicts some degree of cancer risk even at extremely low exposure levels. Many chemicals that produce tumors in experimental animals have been shown to act by epigenetic mechanisms that do not involve an attack by the chemical on DNA leading to subsequent genetic alteration. Such indirect mechanisms require prolonged exposures to high levels of chemicals for the production of tumors. For chemicals that are carcinogenic in this manner, the cancer mechanism would not be operative at exposures below a threshold at which the relevant cellular effect does not occur. Also, in contrast to DNA-reactive mechanisms, epigenetic effects may be unique to the rodent species used for testing.

Certain chemical tumorigens have been well studied and provide examples for the use of mechanistic information in risk assessment. Butylated hydroxyanisole and saccharin are nongenotoxic food additives for which no risk ta humans is predicted based upon low exposure levels and the likelihood that humans are either insensitive or much less sensitive to the tumorigenic effects found in rodent test species. For another non-genotoxic food additive d-limonene, the mechanism that underlies kidney tumor development in male rats is not expected to be operative in humans at all. The pharmaceutical phenobarbital represents a large group of non-genotoxic liver microsome enzyme inducers, which produce liver cancer in mice at levels that are near to therapeutic doses in humans. Epidemiology studies have not shown phenobarbital-related tumors in humans, indicating that humans may be less sensitive to the effects of phenobarbital. The mechanistic considerations involved in the risk assessment of these agents demonstrate that humans are not at risk from current exposure levels of many epigenetic carcinogens.

References (55)

  • GP Schoenig et al.

    Evaluation of the dose response and in utero exposure to saccharin in the rat

    Food Chem Toxicol

    (1985)
  • T Shirai et al.

    Effects of butylated hydroxyanisole, butylated hydroxytoluene and NaCl on gastric carcinogenesis initiated with N-Methyl-N′-nitro-N-nitrosoguanidine in F344 rats

    JNCI

    (1984)
  • JM Taylor et al.

    Chronic toxicity and carcinogenicity to the urinary bladder of sodium saccharin in the in utero-exposed rat

    Toxicol Appl Pharmacol

    (1980)
  • N Tavoloni et al.

    Dose-related effects of phenobarbital on hepatic microsomal enzymes

    Proc Soc Exp Biol Med

    (1983)
  • J Whysner et al.

    International cancer risk assessment: The impact of biologic mechanisms

    Reg Toxicol Pharm

    (1992)
  • J Whysner et al.

    Dose-response promotion by butylated hydroxyanisole in chemically initiated tumors of the rodent forestomach

    Food Chem Toxicol

    (1994)
  • J Whysner et al.

    32P-postlabeling assay for detection of adduct formation by phenobarbital, chlordane and polychlorinated biphenyls in mouse liver DNA

    The Toxicologist

    (1995)
  • GM Williams

    Epigenetic promoting effects of buty-lated hydroxyanisole

    Food Chem Toxicol

    (1986)
  • GM Williams

    Mongenotoxic mechanisms in carcinogenesis

    Banbury Report

    (1987)
  • GM Williams et al.

    Chemical Carcinogenesis

  • S Albertini et al.

    Phenobarbital: Does the positive result in TA 1535 indicate genotoxic properties?

    Environ Mol Mutagen

    (1992)
  • P Armitage et al.

    The age distribution of cancer and multistage theory of carcinogenesis

    Br J Cancer

    (1954)
  • KP Baetcke et al.

    Alphas-globulin association with chemically induced renal toxicity and neoplasia in the male rat

  • SM Cohen et al.

    Promoting effect of saccharin and dl-tryptophan in urinary bladder carcinogenesis

    Cancer Res

    (1979)
  • SM Cohen et al.

    Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids and calcium salts in rats

    Cancer Res

    (1991)
  • Commission Directive 93/67/EEC of July 1993

    Official Journal of the European Communities

    (1993)
  • Cited by (63)

    • Global and region-specific post-transcriptional and post-translational modifications of bisphenol A in human prostate cancer cells

      2019, Environmental Pollution
      Citation Excerpt :

      BPA exposure and action mechanisms associated with chronic diseases could be related to oxidative stress, mitochondrial dysfunctions, genotoxic effects, epigenetic modifications including alterations of cell signaling pathways (Kundakovic and Champagne, 2011; Rezg et al., 2014). Environmental chemicals have been linked to aberrant changes in epigenetic regulation in tumor have been gained considerable attention (Williams and Whysner, 1996; Klaunig et al., 2000; Esteller and Herman, 2002; Bombail et al., 2004; Fleisch et al., 2012; Pogribny and Beland, 2013; Greally ve Jacobs, 2013). BPA exposure could change cellular pathways through epigenetic mechanisms including global and gene-specific DNA methylation, histone modifications, miRNA regulations and also alterations on gene expression levels of chromatin modifying enzymes through in vitro and in vivo studies (Collett et al., 2006; Dolinoy et al., 2007; Avissar-Whiting et al., 2010; Doherty et al., 2010; Chao et al., 2012; Zhou et al., 2013; Singh and Li, 2012; Bhan et al., 2014; Faulk et al., 2015; Ho et al., 2015; Cheong et al., 2016; Hayes et al., 2016; Laing et al., 2016; Anderson et al., 2017; Chen et al., 2017; Kumar and Thakur, 2017; Prins et al., 2017; Desai et al., 2018; Gao et al., 2018; Neff et al., 2019).

    • An integrated approach for prospectively investigating a mode-of-action for rodent liver effects

      2013, Toxicology and Applied Pharmacology
      Citation Excerpt :

      The induction of cytochrome P450 (Cyp) enzyme activity has long been associated with chemically-induced rodent hepatocarcinogenesis (Guengerich, 1988). An example of one such compound that induces tumors through a non-DNA-reactive mechanism involving liver hyperplasia is phenobarbital (PB) (Williams and Whysner, 1996). Rodents chronically treated with PB show activation of CAR as evidenced by elevation of associated gene transcripts (mainly Cyp2b), enzyme activity, hepatocellular proliferation, and eventually proliferative liver lesions (Wei et al., 2000; Yamamoto et al., 2004).

    • Guidelines and pharmacopoeial standards for pharmaceutical impurities: Overview and critical assessment

      2012, Regulatory Toxicology and Pharmacology
      Citation Excerpt :

      TD50 of 2.65 mg/kg/day (an identical value being cited by Cheeseman et al.) shows that the compound has been treated as a strong carcinogen, more potent than many N-nitrosamines, in relation to the determination of the TTC. Simple linear extrapolation is inappropriate for the risk assessment of non-genotoxic compounds (which comprise the majority of the drug substances shown in Table 3, and there are many more in the Bassan et al. dataset) since such compounds are normally considered to be thresholded in relation to dose–response relationships (Williams and Whysner, 1996; EU Scientific Committees, 2009). A further consideration is that numerous structurally alerting compounds in the current CPDB reported as yielding “no positive test” are excluded from the TTC datasets; examples of these compounds, along with their Ames-test status, are shown in Table 4. (

    • Diagnostic Challenge

      2012, Journal of Exotic Pet Medicine
    • Application of the DNA adductome approach to assess the DNA-damaging capability of in vitro micronucleus test-positive compounds

      2011, Mutation Research - Genetic Toxicology and Environmental Mutagenesis
      Citation Excerpt :

      Kirkland et al. demonstrated recently that the results from in vitro genotoxicity tests, especially the chromosome aberration assay and the micronucleus test in Chinese hamster cells and the mouse lymphoma tk locus assay, are highly discrepant from the results from rodent in vivo carcinogenicity tests [1]. Direct or indirect DNA reaction with a compound is an example of MOA, and should be first considered after a positive result is obtained in in vitro genotoxicity tests [2]. Direct DNA-reactive compounds are considered to have a non-effective threshold in the dose–response relationship in carcinogenesis; however, non-DNA-reactive (indirect) compounds have a threshold.

    • Chemicals with Carcinogenic Activity in Rodent Liver

      2010, Comprehensive Toxicology, Second Edition
    View all citing articles on Scopus
    View full text